Amgen to Establish New Technology and Innovation Site in India
Amgen, a biotech giant based in Thousand Oaks, has announced the opening of a new technology and innovation site named Amgen India in Hyderabad. This development, disclosed on August 9, marks a significant expansion as it aims to strengthen their pipeline of medicines.
Why Hyderabad?
The decision to set up in Hyderabad stems from the city's reputation for having world-class talent in medicine, life sciences, and data sciences. The area's rapid advancements in the field of artificial intelligence (AI) have also played a crucial role in this decision. The site will be situated in HITEC City, a tech-centric suburb of Hyderabad, occupying six floors of the RMZ Spire Tower 110.
Operational Details
Set to be operational by the end of the year, the facility will accommodate up to 3,000 employees. This site signifies Amgen's commitment to leveraging the convergence of biotechnology and technology to accelerate innovation in medicine. As per David M. Reese, M.D., Amgen's executive vice president and chief technology officer, this milestone reflects over a decade of preparation to meet the needs of a rapidly aging global population.
Leadership and Roles
Heading the new site will be Som Chattopadhyay, appointed as the national executive for India. The site will offer diverse roles that enhance Amgen's business, including positions in AI, data science, and life sciences. This further solidifies Amgen's global capabilities.
Significance for Hyderabad
According to Chief Minister Sri Anumula Revanth Reddy, Amgen's initiative underscores Hyderabad's status as a hub of innovation and technology. The presence of Amgen, a global leader in biotechnology, in India stands as an inspiration to tech talent keen on making impactful contributions to the global health landscape.
Company Overview and Financials
Amgen employs nearly 27,000 people and has a robust presence in approximately 100 countries worldwide, including India. Recently, Amgen reported its second-quarter earnings for 2024, revealing a revenue of $8.4 billion, marking a 20% year-over-year increase. This financial success underscores the strength and potential of Amgen's expanding global operations.
